To investigate the activity of niraparib in patients with germline-mutated BRCA1/2 (gBRCAm) advanced breast cancer.
Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study
Zoppoli, Gabriele;
2021-01-01
Abstract
To investigate the activity of niraparib in patients with germline-mutated BRCA1/2 (gBRCAm) advanced breast cancer.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Niraparib for_2021_Turner.pdf
accesso aperto
Tipologia:
Documento in versione editoriale
Dimensione
602.87 kB
Formato
Adobe PDF
|
602.87 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
